Thrombectomy Device
- UID
- IMP/MD/2021/000389_7a75b2c01ef04d31925d7499de13e71b_cd89d9878c2ca666752dee558caaf206
- Device class
- Class D
- Brand name
- CREDO Stent
- License holder
- N-VASCULAR TECHNOLOGY PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- Thrombectomy Device is intended for restoration of the arterial flow in patients diagnosed with ischemic stroke due to large intracranial vascular occlusion (CREDO Stent). Patients who fail intravenous thrombolytic therapy or who are ineligible for thrombolysis may be suited for treatment with the Aperio® Hybrid Thrombectomy Device.
Thrombectomy Device is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2021/000389_7a75b2c01ef04d31925d7499de13e71b_cd89d9878c2ca666752dee558caaf206. This device is marketed under the brand name CREDO Stent. The license holder is N-VASCULAR TECHNOLOGY PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.